Cargando…

Drug-related problems in type 2 diabetes mellitus patients with dyslipidemia

BACKGROUND: Drug-Related Problems (DRPs) commonly occur among type 2 diabetes mellitus (T2DM) patients. However, few studies have been performed on T2DM patients with dyslipidemia. This purpose of this study was to assess drug-related problems (DRPs) and factors associated with its occurrence. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zaman Huri, Hasniza, Chai Ling, Lee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890513/ https://www.ncbi.nlm.nih.gov/pubmed/24341672 http://dx.doi.org/10.1186/1471-2458-13-1192

Ejemplares similares

Drug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective study
por: Zaman Huri, Hasniza, et al.
Publicado: (2013)

Glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with renal complications
por: Huri, Hasniza Zaman, et al.
Publicado: (2015)

Association between glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with cardiovascular complications
por: Huri, Hasniza Zaman, et al.
Publicado: (2015)

Drug-related problems in patients with rheumatoid arthritis
por: Ma, Shu Ning, et al.
Publicado: (2019)

Drug-related problems in patients with erectile dysfunctions and multiple comorbidities
por: Huri, Hasniza Zaman, et al.
Publicado: (2017)

Drug-Related Problems in Patients with Benign Prostatic Hyperplasia: A Cross Sectional Retrospective Study
por: Zaman Huri, Hasniza, et al.
Publicado: (2014)

Factors Associated with Utilization of Dipeptidyl-4 Inhibitors in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Retrospective Study
por: Zaman Huri, Hasniza, et al.
Publicado: (2014)

Potential Biomarkers of Insulin Resistance and Atherosclerosis in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease
por: Syed Ikmal, Sharifah Intan Qhadijah, et al.
Publicado: (2013)

Statin Therapy Prescribing for Patients with Type 2 Diabetes Mellitus: A Review of Current Evidence and Challenges
por: Elnaem, Mohamed Hassan, et al.
Publicado: (2017)

Association of DPP4 Gene Polymorphisms with Type 2 Diabetes Mellitus in Malaysian Subjects
por: Ahmed, Radwan H., et al.
Publicado: (2016)

Heart Failure With Type 2 Diabetes Mellitus: Association Between Antihyperglycemic Agents, Glycemic Control, and Ejection Fraction
por: Lin, Shu Ning, et al.
Publicado: (2020)

Sliding-Scale versus Basal-Bolus Insulin in the Management of Severe or Acute Hyperglycemia in Type 2 Diabetes Patients: A Retrospective Study
por: Zaman Huri, Hasniza, et al.
Publicado: (2014)

Effectiveness and prescription pattern of lipid-lowering therapy and its associated factors among patients with type 2 diabetes mellitus in Malaysian primary care settings
por: Elnaem, Mohamed Hassan, et al.
Publicado: (2019)

Genetic Markers of Insulin Resistance and Atherosclerosis in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease
por: Perumalsamy, Sangeetha, et al.
Publicado: (2023)

Retinol-Binding Protein-4—A Predictor of Insulin Resistance and the Severity of Coronary Artery Disease in Type 2 Diabetes Patients with Coronary Artery Disease
por: Perumalsamy, Sangeetha, et al.
Publicado: (2021)

Pharmacist-led academic detailing improves statin therapy prescribing for Malaysian patients with type 2 diabetes: Quasi-experimental design
por: Elnaem, Mohamed Hassan, et al.
Publicado: (2019)

Serum Levels of Soluble CD26/Dipeptidyl Peptidase-IV in Type 2 Diabetes Mellitus and Its Association with Metabolic Syndrome and Therapy with Antidiabetic Agents in Malaysian Subjects
por: Ahmed, Radwan H., et al.
Publicado: (2015)

Single Nucleotide Polymorphism rs17173608 in the Chemerin Encoding Gene: Is It a Predictor of Insulin Resistance and Severity of Coronary Artery Disease in Non-Obese Type 2 Diabetes?
por: Perumalsamy, Sangeetha, et al.
Publicado: (2021)

Dyslipidemia in Pediatric Type 2 Diabetes Mellitus
por: Sunil, Bhuvana, et al.
Publicado: (2020)

Chronic Kidney Disease Screening Methods and Its Implication for Malaysia: An in Depth Review
por: Almualm, Yasmin, et al.
Publicado: (2015)

Medication Adherence for Haemophilia Patients: Outcome of Prophylaxis Treatment Intervention
por: Mokhtar, Fadzlin Mohd, et al.
Publicado: (2021)

Pharmacokinetic–Pharmacometabolomic Approach in Early-Phase Clinical Trials: A Way Forward for Targeted Therapy in Type 2 Diabetes
por: Tee, Khim Boon, et al.
Publicado: (2022)

The Role of Dyslipidemia Control in the Progression of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus
por: Chatziralli, Irini P.
Publicado: (2017)

Oral drug treatments in patients with erectile dysfunction and multiple comorbidities: a retrospective observational study
por: Zaman Huri, Hasniza, et al.
Publicado: (2014)

Association of Met420del Variant of Metformin Transporter Gene SLC22A1 with Metformin Treatment Response in Ethiopian Patients with Type 2 Diabetes
por: Degaga, Abraham, et al.
Publicado: (2023)

Pharmacists Intervention Reduced Drug-Related Problems in the Treatment of Patients with Type 2 Diabetes Mellitus
por: Nasution, Azizah, et al.
Publicado: (2019)

Drug-related problems in hospitalized patients with type 2 diabetes mellitus: A systematic review
por: Awang Jihadi, Mohammad Hisyamuddin, et al.
Publicado: (2023)

Prevalence and pattern of dyslipidemia in patients with type 2 diabetes mellitus in Zaria, Northwestern Nigeria
por: Bello-Ovosi, Beatrice Ohunene, et al.
Publicado: (2019)

Prevalence of Dyslipidemia in Patients With Type 2 Diabetes Mellitus: A Cross-Sectional Study
por: Al Ghadeer, Hussain A, et al.
Publicado: (2021)

Association of Dyslipidemia with Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients: A Hospital-Based Study
por: Ezhilvendhan, Kalaimamani, et al.
Publicado: (2021)

Dyslipidemia and serum cystatin C levels as biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus
por: Dejenie, Tadesse Asmamaw, et al.
Publicado: (2023)

The Effect of Drug-Related Problems on Blood Glucose Level in the Treatment of Patients with Type 2 Diabetes Mellitus
por: Hartuti, Silvy, et al.
Publicado: (2019)

Association of psychological factors, patients’ knowledge, and management among patients with erectile dysfunction
por: Huri, Hasniza Zaman, et al.
Publicado: (2016)

Effect of Atorvastatin on Growth Differentiation Factor-15 in Patients with Type 2 Diabetes Mellitus and Dyslipidemia
por: Kim, Ji Min, et al.
Publicado: (2016)

LDLR C1725T Gene Polymorphism Frequency in Type 2 Diabetes Mellitus Patients With Dyslipidemia
por: Eroglu, Zuhal, et al.
Publicado: (2016)

Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus
por: Kong, Sung Hye, et al.
Publicado: (2017)

Circulating lymphocytes and monocytes transcriptomic analysis of patients with type 2 diabetes mellitus, dyslipidemia and periodontitis
por: Corbi, Sâmia C. T., et al.
Publicado: (2020)

Dyslipidemia among Patients with Type 2 Diabetes Mellitus Visiting a Tertiary Care Centre
por: Khadka, Bikram, et al.
Publicado: (2023)

The prevalence of dyslipidemia in patients with diabetes mellitus of ayurveda Hospital
por: Dixit, Amit Kumar, et al.
Publicado: (2014)

Apoptotic induction and inhibition of NF-κB signaling pathway in human prostatic cancer PC3 cells by natural compound 2,2′-oxybis (4-allyl-1-methoxybenzene), biseugenol B, from Litsea costalis: an in vitro study
por: Abbaspour Babaei, Maryam, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_n71ai1fsdvvn2lr1agic6k956k